Nangia-Makker, P.; Ahrens, M.; Purandare, N.; Aras, S.; Li, J.; Gurdziel, K.; Jang, H.; Kim, S.; Shekhar, M.P.
Inter-Relationship Between Melanoma Vemurafenib Tolerance Thresholds and Metabolic Pathway Choice. Cells 2025, 14, 923.
https://doi.org/10.3390/cells14120923
AMA Style
Nangia-Makker P, Ahrens M, Purandare N, Aras S, Li J, Gurdziel K, Jang H, Kim S, Shekhar MP.
Inter-Relationship Between Melanoma Vemurafenib Tolerance Thresholds and Metabolic Pathway Choice. Cells. 2025; 14(12):923.
https://doi.org/10.3390/cells14120923
Chicago/Turabian Style
Nangia-Makker, Pratima, Madison Ahrens, Neeraja Purandare, Siddhesh Aras, Jing Li, Katherine Gurdziel, Hyejeong Jang, Seongho Kim, and Malathy P Shekhar.
2025. "Inter-Relationship Between Melanoma Vemurafenib Tolerance Thresholds and Metabolic Pathway Choice" Cells 14, no. 12: 923.
https://doi.org/10.3390/cells14120923
APA Style
Nangia-Makker, P., Ahrens, M., Purandare, N., Aras, S., Li, J., Gurdziel, K., Jang, H., Kim, S., & Shekhar, M. P.
(2025). Inter-Relationship Between Melanoma Vemurafenib Tolerance Thresholds and Metabolic Pathway Choice. Cells, 14(12), 923.
https://doi.org/10.3390/cells14120923